Polymorphisms of the tumor necrosis factor-α gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma

Blood

Volumn 100, Issue 6, 2002, Pages 2263-2265

  Neben, Kai ^a   Mytilineos, Joannis ^a   Moehler, Thomas M ^a   Preiss, Astrid ^a   Kraemer, Alwin ^a   Ho, Anthony D ^a   Opelz, Gerhard ^a   Goldschmidt, Hartmut ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER RESISTANCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; OUTCOMES RESEARCH; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0037105593     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v100.6.2263.h81802002263_2263_2265     Document Type: Article

References (20)

1. Thalidomide selectively inhibits tumor necrosis factor production by stimulated human monocytes
2. The treatment of lepra reaction in lepromatous leprosy. Fifteen years' experience with thalidomide
3. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum
4. Tumor necrosis factor-α and interleukin 4 in myeloma cell precursor differentiation
5. Tumor necrosis factor type α, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo
6. The role of interleukin-1 and tumour necrosis factor-α in human multiple myeloma
7. Relative contribution of transcription and translation to the induction of tumor necrosis factor-α by lipopolysaccharide
8. The -308 tumor necrosis factor-α promoter polymorphism effects transcription
9. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation
10. A polymorphie variation in a putative regulation box of the TNFA promoter region
11. Single base polymorphism in the human tumour necrosis factor alpha (TNF α) gene detectable by Ncol restriction of PCR product
12. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
13. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis
14. Tumour necrosis factor α gene polymorphisms in rheumatoid arthritis: Association with susceptibility to, or severity of, disease?
15. High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma
16. PCR-SSP typing for IL10, TNF-α and TGF-β promoter gene polymorphisms in caucasian and African American individuals
17. A clinical staging system for multiple myeloma
18. Production of cytokines by bone marrow cells obtained from patients with multiple myeloma
19. High-producer haplotypes of tumor necrosis factor α and lymphotoxin α are associated with an increased risk of myeloma and have an improved progression-free survival after treatment
20. Identification and characterization of a novel repressor site in the human tumor necrosis factor a gene